<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cardiovasc Drugs Ther</journal-id><journal-id journal-id-type="iso-abbrev">Cardiovasc Drugs Ther</journal-id><journal-title-group><journal-title>Cardiovascular Drugs and Therapy</journal-title></journal-title-group><issn pub-type="ppub">0920-3206</issn><issn pub-type="epub">1573-7241</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38878138</article-id><article-id pub-id-type="pmc">PMC11680631</article-id>
<article-id pub-id-type="publisher-id">7582</article-id><article-id pub-id-type="doi">10.1007/s10557-024-07582-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Invited: BSCR Marshall Submissions</subject></subj-group></article-categories><title-group><article-title>A Mitochondrial Basis for Heart Failure Progression</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2279-6594</contrib-id><name><surname>Watson</surname><given-names>William D.</given-names></name><address><email>ww265@cam.ac.uk</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Arvidsson</surname><given-names>Per M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Miller</surname><given-names>Jack J. J.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Lewis</surname><given-names>Andrew J.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Rider</surname><given-names>Oliver J.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/013meh722</institution-id><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2188 5934</institution-id><institution>Division of Cardiovascular Medicine, </institution><institution>University of Cambridge, </institution></institution-wrap>Cambridge, UK </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/052gg0110</institution-id><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution>Oxford Centre for Magnetic Resonance Research, </institution><institution>University of Oxford, </institution></institution-wrap>Oxford, UK </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012a77v79</institution-id><institution-id institution-id-type="GRID">grid.4514.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0930 2361</institution-id><institution>Clinical Physiology, Department of Clinical Sciences Lund, </institution><institution>Lund University, </institution></institution-wrap>Lund, Sweden </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02z31g829</institution-id><institution-id institution-id-type="GRID">grid.411843.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0623 9987</institution-id><institution>Department of Clinical Physiology, </institution><institution>Sk&#x000e5;ne University Hospital, </institution></institution-wrap>Lund, Sweden </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01aj84f44</institution-id><institution-id institution-id-type="GRID">grid.7048.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 1956 2722</institution-id><institution>Department of Clinical Medicine, </institution><institution>Aarhus University, </institution></institution-wrap>Aarhus, Denmark </aff></contrib-group><pub-date pub-type="epub"><day>15</day><month>6</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>6</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2024</year></pub-date><volume>38</volume><issue>6</issue><fpage>1161</fpage><lpage>1171</lpage><history><date date-type="accepted"><day>20</day><month>5</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">In health, the human heart is able to match ATP supply and demand perfectly. It requires 6&#x000a0;kg of ATP per day to satisfy demands of external work (mechanical force generation) and internal work (ion movements and basal metabolism). The heart is able to link supply with demand via direct responses to ADP and AMP concentrations but calcium concentrations within myocytes play a key role, signalling both inotropy, chronotropy and matched increases in ATP production. Calcium/calmodulin-dependent protein kinase (CaMKII) is a key adapter to increased workload, facilitating a greater and more rapid calcium concentration change. In the failing heart, this is dysfunctional and ATP supply is impaired. This review aims to examine the mechanisms and pathologies that link increased energy demand to this disrupted situation. We examine the roles of calcium loading, oxidative stress, mitochondrial structural abnormalities and damage-associated molecular patterns.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Heart failure</kwd><kwd>Mitochondria</kwd><kwd>Redox</kwd><kwd>Calcium</kwd><kwd>ATP</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media, LLC, part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">In health, the heart has an incredible ability to respond directly to loading and demand changes to keep up with the body&#x02019;s requirements. In addition, myocyte mitochondria are able to precisely match ATP supply with demand.</p><p id="Par3">However, any heart placed under prolonged and excessive load will, over time, fail. This is used experimentally to induce heart failure (for instance, rapid pacing or aortic constriction) but is also seen clinically (high output heart failure, tachycardia-mediated cardiomyopathy or valvular heart disease leading to pressure or volume loading). This process involves mechanical remodelling of the ventricle, hypertrophy and fibrosis of the myocardium, inflammatory cell infiltrate and alterations to cellular pathways within myocytes themselves leading to hypertrophy and apoptosis. It affects all cells and components of the heart cardiomyocytes, fibroblasts, endothelium and interstitium [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The geometry of the heart changes from an elliptical to spherical shape, further compromising its contractile function. After an initiating event, these mechanisms will cause constant progression of heart failure unless checked. The pathways involved are incompletely mapped and it is unclear which cause physiological adaptations to pressure or volume loading and which cause pathological adaptations [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par4">The aim of this review is to understand how hearts respond to load, the adaptive and maladaptive cellular responses that ensue in different high-load states and how mitochondria may play a role in the progression of heart failure.</p></sec><sec id="Sec2"><title>Energy Requirements of the Heart</title><sec id="Sec3"><title>Mechanical Energy Requirements</title><p id="Par5">From basic mechanical principles, we can ascertain that the work done by the left ventricle will be proportional to the volume of blood pumped and the pressure against which it must be pumped.</p><p id="Par6">The most simplistic approach is rate pressure product (RPP), the heart rate multiplied by the systolic blood pressure.</p><p id="Par7">Plotting left ventricular pressure against volume for the cardiac cycle forms a loop (a pressure&#x02013;volume loop) with its area corresponding to the mechanical work done in each cardiac cycle. By extending the loop to an intercept on the x-axis, this forms the pressure&#x02013;volume area (PVA), which models the mechanical energy required within a stretching heart using a time-varying elastance model (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Suga&#x02019;s group correlated PVA derived from pressure&#x02013;volume loops recorded from isolated canine hearts with myocardial oxygen uptake (MVO<sub>2</sub>, an indicator of energy substrate oxidation and hence ATP demand) and found the correlation was good in an individual heart in the baseline state [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>] but varied from heart to heart [<xref ref-type="bibr" rid="CR7">7</xref>] and with levels of catecholaminergic stimulation [<xref ref-type="bibr" rid="CR8">8</xref>]. Total MVO2 will include the basal metabolism and energy expended in ion transport (predominantly calcium) which are independent of PVA, as well as the actin-myosin cross-bridge cycling which is proportional to PVA. Increased contractility is due to changes in calcium cycling hence shifts the relationship between MVO2 and mechanical work upwards [<xref ref-type="bibr" rid="CR9">9</xref>].<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Pressure&#x02013;volume loop and pressure&#x02013;volume area. The PV loop begins at beginning of diasystole (<bold>A</bold>) and fills through diastole to point <bold>B</bold>. From B to C is the beginning of systole (isovolumic contraction) where pressure rises but the aortic valve is closed and volume does not change. At point <bold>C</bold>, left ventricular pressure exceeds aortic diastolic pressure and the aortic valve opens, leading to ejection and a fall in left ventricular volume down to point <bold>D</bold>, where the aortic valve closes. From D to A, left ventricular rapidly falls and the cycle begins again. The pressure&#x02013;volume loop and the triangular dark shaded area to the left form the pressure&#x02013;volume area (PVA). The smaller, grey loop to the right represents an example of the PV loop in heart failure</p></caption><graphic xlink:href="10557_2024_7582_Fig1_HTML" id="MO1"/></fig></p><p id="Par8">The mechanical work done, which is quantified in PVA, is often referred to as &#x02018;external work&#x02019; and the energy expended in basal metabolism and ion transport is referred to as &#x02018;internal work&#x02019;. The efficiency of the system may be defined as the ratio between ventricular stroke work and oxygen consumption [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par9">In heart failure, the pressure&#x02013;volume loop is shifted to the right owing to dilation of the ventricle, increasing PVA and hence energy requirements [<xref ref-type="bibr" rid="CR11">11</xref>]. The relationship between mechanical dyssynchrony and oxygen consumption is more complicated: in acute studies, both oxygen consumption and mechanical work done increased following resynchronisation, however mechanical work increased more&#x000a0;than oxygen consumption, hence making the ventricle more efficient [<xref ref-type="bibr" rid="CR12">12</xref>], presumably down to global mechanical work not representing individual segmental work. Efficiency increased following aneurysmectomy [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par10">Phosphorus-31 cardiac magnetic resonance subsequently allowed determination of ATP flux through the creatine kinase reaction in vivo, which has confirmed that ATP flux can vary significantly with loading conditions within the same heart in spite of minimal change in rate pressure product or PVA [<xref ref-type="bibr" rid="CR14">14</xref>]. This suggests a large contribution to changes in ATP demand comes from alterations in internal work.</p><p id="Par11">Modelling whole-heart energy requirement has proven challenging. Mechanical energy requirements may be similarly calculated for the right ventricle [<xref ref-type="bibr" rid="CR15">15</xref>] and the atria [<xref ref-type="bibr" rid="CR16">16</xref>] but how relationships change with geometric alterations to the LV is unclear. In addition, calculating the ATP requirements for internal work has yet to be done reliably. An overarching model to link myocardial energy consumption to the different factors affecting it is therefore lacking.</p></sec><sec id="Sec4"><title>How the Energy Demand Is Met</title><p id="Par12">The process of transforming metabolic substrates into usable energy has been extensively reviewed elsewhere [<xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>]. In brief: it can be divided into three stages of substrate metabolism, oxidative phosphorylation and phosphotransfer. Metabolic substrates are taken up by the heart, principally free fatty acids (60&#x02013;90%) and glucose (10&#x02013;40%) but with a lesser contribution from ketones, lactate and amino acids. Glucose enters glycolysis and fatty acids beta-oxidation to produce Acetyl Co-enzyme A which can enter the tricarboxylic acid (or Krebs) cycle. The tricarboxylic acid cycle produces the reducing intermediates NADPH and FADH2, which in turn feeds into the electron transport chain, creating an electron gradient across the inner mitochondrial membrane. This gradient is used by the enzyme F1F0 ATPase to produce ATP from ADP. To facilitate ATP transport around the cell, ATP transfers a phosphate group to creatine to form phosphocreatine, which can rapidly move to sites of ATP demand, where it reacts with ADP to re-form ATP.</p><p id="Par13">Two abilities are key. First, keeping up a high rate of ATP production that matches the heart&#x02019;s constantly changing demand. The second, related ability is to retain a large concentration difference between [ATP] and [ADP]. This determines the energy of hydrolysis of ATP (&#x00394;G<sub>ATP</sub>): enzymes require &#x00394;G<sub>ATP</sub> to remain above a certain amount to function, for instance while actin-myosin cross-bridge cycling requires a large turnover of ATP, SERCA requires a higher &#x00394;G<sub>ATP.</sub> These factors are determined by both mitochondrial activity and a system of phosphotransfer, which shuttles high-energy phosphate to its sites of use.</p></sec></sec><sec id="Sec5"><title>How Energy Supply and Demand Are Matched</title><p id="Par14">The heart has a remarkable ability to match ATP synthesis to hydrolysis with cardiac oxygen consumption, increasing proportionately with workload but intracellular ATP concentrations and &#x00394;G<sub>ATP</sub> remaining constant [<xref ref-type="bibr" rid="CR20">20</xref>]. In the healthy heart, PCr/ATP remains constant under moderate stress, [<xref ref-type="bibr" rid="CR21">21</xref>] [<xref ref-type="bibr" rid="CR22">22</xref>] suggesting that at these workloads there is sufficient ability to increase substrate metabolism, oxidative phosphorylation and phosphotransfer rates to meet the increased ATP demand. Multiple processes (calcium levels, AMP signalling, coupled reactions) interact to produce this balance [<xref ref-type="bibr" rid="CR23">23</xref>].</p><sec id="Sec6"><title>High-Energy Phosphate Metabolism and ATP</title><p id="Par15">The role of phosphorus in energy transfer is summarised in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>. Increased ATPase activity alters ATP/ADP balance at sites of use, with the phosphotransfer mechanism also acting as a feedback system to change this balance within the mitochondria or other sensitive areas. An increase in reaction substrates at the mitochondrion (ADP and Pi) increases the rate of oxidative phosphorylation [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], which in turn leads to a change in flux through the Krebs cycle and a decrease in Krebs cycle intermediates and other reactants. For instance, a fall in Acetyl CoA leads to an increase in fatty acid transport, while a fall in citrate stimulates glycolysis [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Diagrammatic illustration of the linkage between ATP supply and demand via phosphate shuttles and with regulation by calcium. Changes in concentrations of ATP, ADP and phosphate (Pi) will shift the equilibrium of the creatine kinase reaction, increasing ADP near mitochondria and stimulating oxidative phosphorylation and the Krebs cycle. Increases in intracellular calcium stimulate both contraction and mitochondrial ATP production, harmonising the two processes</p></caption><graphic xlink:href="10557_2024_7582_Fig2_HTML" id="MO2"/></fig></p><p id="Par16">AMPK (AMP-activated protein kinase) promotes ATP production during higher workloads or oxidative stress, being activated by an increase in AMP (adenylate kinase converts 2 ADP into an ATP and AMP when ADP levels rise) [<xref ref-type="bibr" rid="CR27">27</xref>]. AMPK inhibits ATP consuming processes (e.g. biosynthetic pathways) and turns on ATP-generating fatty acid oxidation and glycolysis via various routes, activating Acetyl CoA carboxylase and phosphofructokinase and recruiting the glucose transporter GLUT-4 to the plasma membrane [<xref ref-type="bibr" rid="CR28">28</xref>].</p></sec><sec id="Sec7"><title>Calcium as a Master Regulator of Contraction and Energetics</title><p id="Par17">Calcium acts as a master regulator: increased cytosolic calcium is the signal to initiate contraction (using ATP) but it also enters mitochondria via the mitochondrial calcium transporter, stimulating an increase in Krebs cycle reactions (several of the enzymes are calcium dependent), increasing mitochondrial ATP production in a fashion that matches the increased ATP requirement [<xref ref-type="bibr" rid="CR29">29</xref>]. Mitochondrial calcium regulates pyruvate dehydrogenase, isocitrate dehydrogenase and alpha-ketoglutarate dehydrogenase [<xref ref-type="bibr" rid="CR30">30</xref>], key steps in glucose metabolism, as well as the F1F0 ATPase responsible for ATP generation [<xref ref-type="bibr" rid="CR31">31</xref>]. Via calcium-calmodulin-dependent kinase, calcium signals translocation of glucose and fat transporters from the sarcolemma to the cell membrane [<xref ref-type="bibr" rid="CR32">32</xref>].</p><p id="Par18">When beta-adrenoreceptor stimulation occurs, the redox state of NADH/NAD&#x02009;+&#x02009;and FADH2/FAD transiently oxidises (ADP accumulation accelerating respiration and using up reducing intermediates), followed by mitochondrial Ca2&#x02009;+&#x02009;uptake which increases Krebs activity and regenerates redox states [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. If the mitochondrial calcium transporter is blocked, there is net oxidation of NADH/NAD&#x02009;+&#x02009;and FADH2/FAD reduced ETC activity [<xref ref-type="bibr" rid="CR35">35</xref>], while if mitochondrial calcium transporter is deleted, pyruvate dehydrogenase activity is impaired causing increased fatty acid oxidation with a reduction in myocardial glycose oxidation [<xref ref-type="bibr" rid="CR36">36</xref>] and there is delayed mitochondrial and contractile response to beta-adrenoreceptor stimulation [<xref ref-type="bibr" rid="CR37">37</xref>]. Calcium is effluxed from mitochondria by the Na&#x02009;+&#x02009;-Ca2&#x02009;+&#x02009;-Li&#x02009;+&#x02009;exchanger (NCLX), exchanged for sodium ions [<xref ref-type="bibr" rid="CR38">38</xref>].</p></sec><sec id="Sec8"><title>Mechanotransduction</title><p id="Par19">Mechanotransduction is the ability of cells to transduce physical stimuli into molecular signals. Biochemical and biophysical signalling pathways exist: biophysical pathways link the internal and external cellular dimensions together, leading to the exposure of activation domains on intracellular proteins when force is exerted while biochemical pathways are stress sensors (e.g. GTPases) activated when the cell is physically stressed [<xref ref-type="bibr" rid="CR39">39</xref>]. The sarcomere, the intercalated disc and the sarcolemma are key sites of mechanotransduction [<xref ref-type="bibr" rid="CR40">40</xref>].</p><p id="Par20">Mechanical stretch results in calcium influx being induced by stretch-activated channels [<xref ref-type="bibr" rid="CR39">39</xref>], with the initial increase in calcium spark being found to be mediated by components of the cytoskeleton [<xref ref-type="bibr" rid="CR41">41</xref>].</p></sec></sec><sec id="Sec9"><title>Adaptation to High Demand</title><sec id="Sec10"><title>Calcium/Calmodulin-Dependent Protein Kinase</title><p id="Par21">Ca2&#x02009;+&#x02009;/calmodulin-dependent protein kinase (CaMKII) is present in cardiac myocytes and activated by binding calcium/calmodulin complexes. Its activities are summarised in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>. It is involved in regulation of the excitation&#x02013;contraction coupling, transducing the effect of beta-adrenoreceptor activation on the sinoatrial node to increase heart rate, acting as a physiological adaptor to higher heart rates by increasing strength of contraction and rate of relaxation in the short term and adjusting cardiac gene expression to cause hypertrophy in the long term [<xref ref-type="bibr" rid="CR42">42</xref>]. However, oxidation by reactive oxygen species causes persistent activation (until reversed by the action of methionine sulfoxide reductase [<xref ref-type="bibr" rid="CR43">43</xref>]) and over-activation causes structural and electric remodelling, leading to reduced contractility, arrhythmia and apoptosis [<xref ref-type="bibr" rid="CR44">44</xref>].<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Signalling pathways linking calcium, reactive oxygen species (ROS), calcium-calmodulin-dependent kinase (CaMKII) and their downstream effects. Intracellular calcium enters the cell via L-type calcium channels (LTCC), enters the mitochondrion via mitochondrial calcium uniporter (MCU) to stimulate the citric acid cycle, activates CaMKII and is taken up into the sarcoplasmic reticulum via the sarcoplasm-endoplasmic reticulum ATPase (SERCA). CaMKII is activated by intracellular calcium, reactive oxygen species (ROS) production and beta-adrenoreceptors. It increases intracellular calcium levels by inhibiting SERCA and activating ryanodine receptor (RyR), as well as causing hypertrophic gene expression by activating histone deacetylases (HDACs). The sodium-calcium exchanger (NCLX) exchanges sodium and calcium across the mitochondrial membrane</p></caption><graphic xlink:href="10557_2024_7582_Fig3_HTML" id="MO3"/></fig></p><p id="Par22">CaMKII causes &#x02018;facilitation&#x02019;, the process by which inward currents though L-type calcium channels (LTCCs) are augmented as intracellular calcium concentrations rise [<xref ref-type="bibr" rid="CR45">45</xref>], facilitating calcium entry into the cytoplasm with longer channel openings. CaMKII phosphorylates ryanodine receptors (RyR2, altering the channel open probability) and phospholamban (PLB, regulating calcium uptake) [<xref ref-type="bibr" rid="CR46">46</xref>]: the sum of these actions being to increase contractile force during a shorter cardiac cycle. And, via entry into mitochondria, a concomitant increase in ATP production. CaMKII also increases re-uptake and sequestration of Ca2&#x02009;+&#x02009;in the sarcoplasmic reticulum by SERCA activation, speeding diastolic relaxation [<xref ref-type="bibr" rid="CR47">47</xref>].</p></sec></sec><sec id="Sec11"><title>Impaired EC Coupling and Altered Calcium Handling Impair the Link Between Contraction and Mitochondrial Activity</title><p id="Par23">Deterioration of cytosolic calcium handling weakens the link between contraction and ATP production. Sarcoplasmic reticulum calcium content is reduced (thanks to RyR2 leak) and SERCA activity is reduced. Systolic function is impaired as the magnitude and speed of the cytosolic Ca2&#x02009;+&#x02009;transient is reduced, while diastolic function suffers owing to slowed [Ca] decay and higher diastolic [Ca].</p><p id="Par24">The mitochondria and sarcoplasmic reticulum are closely coupled in [Ca2&#x02009;+] [<xref ref-type="bibr" rid="CR48">48</xref>]; hence, mitochondrial calcium content is reduced and the NCX operates in reverse mode, although this is insufficient to maintain [Ca2&#x02009;+] [<xref ref-type="bibr" rid="CR35">35</xref>]. A reduction in mitochondrial Ca2&#x02009;+&#x02009;uptake results in relative oxidation of NADH/NAD&#x02009;+&#x02009;and FADH2/FAD&#x02009;+&#x02009;[<xref ref-type="bibr" rid="CR35">35</xref>], giving rise to oxidative stress and ROS production, while correcting this defect in myocytes from failing hearts restored energy supply&#x02013;demand matching [<xref ref-type="bibr" rid="CR49">49</xref>]. Blocking L-type calcium channels or buffering calcium prevented stretch-induced apoptosis [<xref ref-type="bibr" rid="CR50">50</xref>].</p><p id="Par25">Other theories suggest that heart failure causes an increase in mitochondrial [Ca2&#x02009;+]. It is worth noting that there are multiple populations of mitochondria within myocytes and effects may differ [<xref ref-type="bibr" rid="CR51">51</xref>]. Mitochondrial calcium overload activates mitochondrial permeability transition pore (MPTP) opening, dissipating the gradient across the mitochondrial membrane and releasing pro-apoptotic factors leading to cell death (or, alternatively, if a large number of mitochondria are permeabilised the ATP deficit leads to cell necrosis) [<xref ref-type="bibr" rid="CR52">52</xref>].</p><sec id="Sec12"><title>Calcium/Calmodulin-Dependent Protein Kinase in Heart Failure</title><p id="Par26">Unfortunately, CaMKII is a causative pathway in adverse remodelling, owing to its longer term effects elicited by changes in calcium homeostasis and altered calcium handling. Beta-adrenoreceptors associate with CaMKII to couple increased cAMP to CaMKII activation [<xref ref-type="bibr" rid="CR53">53</xref>], while sustained beta-1 adrenoreceptor activation leads to increased free calcium and sarcoplasmic reticulum calcium overload culminating in CaMKII-mediated apoptosis [<xref ref-type="bibr" rid="CR54">54</xref>]. In heart failure states, there is increased calcium influx, SR calcium leak and generally calcium overload, setting up a feed-forward effect where CaMKII further increases the activity of the LTCC, worsening calcium loading [<xref ref-type="bibr" rid="CR45">45</xref>]. ROS is known to be increased in failing hearts and the activation of CaMKII by ROS links this to early after depolarisations via LTCC enhancement and impaired sodium channel activation, both of which are facilitated by CaMKII activation [<xref ref-type="bibr" rid="CR55">55</xref>].</p><p id="Par27">CaMKII appears to be a key link in translating pressure overload to failure as CaMKII knock-out mice subjected to aortic banding exhibited none of the features of failure (chamber dilation, ventricular dysfunction, fibrosis) that wild-type animals did but, interestingly, comparable hypertrophy [<xref ref-type="bibr" rid="CR56">56</xref>]. CaMKII regulates HDACs which control hypertrophic gene pathways, for instance phosphorylating HDAC4 which results in activation of the transcription factor Myocyte Enhancer Factor 2 [<xref ref-type="bibr" rid="CR57">57</xref>].</p></sec></sec><sec id="Sec13"><title>The Failing Heart Is an Engine Out of Fuel</title><sec id="Sec14"><title>Energetic Deficit</title><p id="Par28">A unifying common phenomenon in the progression to failure is an energetic defect in the myocardium [<xref ref-type="bibr" rid="CR58">58</xref>], an umbrella term describing changes in the Gibbs free energy of hydrolysis of ATP, reduction of the pool of phosphocreatine (the myocyte&#x02019;s immediate temporal and spatial energy reserve) and impaired maximal ATP output. In humans, both the ratio of phosphocreatine to ATP [<xref ref-type="bibr" rid="CR59">59</xref>] and the rate of phosphotransfer of ATP via creatine kinase [<xref ref-type="bibr" rid="CR60">60</xref>] correlate with heart failure outcomes.</p><p id="Par29">Whether this is a driver of heart failure or an epiphenomenon (or both) has yet to be conclusively proven, as while over-expression of creatine kinase attenuates dysfunction and improves survival in pressure overload&#x02013;induced heart failure in mice [<xref ref-type="bibr" rid="CR61">61</xref>], deletion does not induce heart failure progression [<xref ref-type="bibr" rid="CR62">62</xref>]. Improving substrate availability with lipid supplementation does however improve PCr/ATP ratio in heart failure [<xref ref-type="bibr" rid="CR63">63</xref>].</p></sec><sec id="Sec15"><title>Mitochondrial Morphology in Heart Failure</title><p id="Par30">Morphological changes in heart failure include reduced mitochondrial area with mitochondrial fragmentation, cristae destruction, vacuolation and swelling [<xref ref-type="bibr" rid="CR64">64</xref>], myelinization and membrane disruption [<xref ref-type="bibr" rid="CR65">65</xref>]. Volume loading resulted in mitochondrial swelling and loss of cristae electron density, something that was preserved by administration of allopurinol or MitoQ, suggesting a role of ROS [<xref ref-type="bibr" rid="CR66">66</xref>].</p><p id="Par31">Mitochondrial fission is increased in heart failure and CaMKII phosphorylates and activates a protein involved in fission, dynamin-related protein 1 (Drp1) [<xref ref-type="bibr" rid="CR67">67</xref>] and fusion is reduced due to reductions in fusion proteins such as optic atrophy 1 (OPA1) [<xref ref-type="bibr" rid="CR68">68</xref>]. Mitophagy, the process by which damaged mitochondria are scavenged so that their contents can be re-used which is important for normal functioning [<xref ref-type="bibr" rid="CR69">69</xref>], is impaired in heart failure with proteins required for the pathway reduced [<xref ref-type="bibr" rid="CR70">70</xref>].</p></sec></sec><sec id="Sec16"><title>Mitochondrial Changes Under Stress Driving Cellular Damage</title><sec id="Sec17"><title>Reactive Oxygen Species</title><p id="Par32">ROS is a broad term used to refer to reactive chemical species derived from oxygen, including OH<sup>&#x02212;</sup>, O<sub>2</sub><sup>2&#x02212;</sup> and H<sub>2</sub>O<sub>2</sub>. &#x02018;Oxidative stress&#x02019; has come to be defined as the imbalance between ROS generation and antioxidant defence [<xref ref-type="bibr" rid="CR71">71</xref>].</p><p id="Par33">Electrons are normally transferred along the electron transport chain to reduce oxygen at complex IV and form water. Electrons &#x02018;leaking&#x02019; (being transferred to other species prior to this) through complexes I and III in the electron transport chain result in oxygen being partially reduced to superoxide, which is converted to hydrogen peroxide by superoxide dismutase (SOD). Hydrogen peroxide is eliminated by antioxidant enzymes, mostly requiring NADPH as an electron donor. As mentioned above, impaired mitochondrial calcium uptake under pathological workloads results in ADP concentration outstripping ETC capacity, resulting in a less oxidised NADH/NAD&#x02009;+&#x02009;pair: this reduces the NADH available to form the antioxidant NADPH [<xref ref-type="bibr" rid="CR72">72</xref>]. Succinate accumulates during cardiac ischaemia and induces reverse electron transport during reperfusion, causing a damaging surge of ROS generation [<xref ref-type="bibr" rid="CR73">73</xref>], proposed as the mechanism for ischaemia&#x02013;reperfusion injury. Deterioration of mitochondrial calcium uptake seen in heart failure results in a fall in regeneration of the reduced forms of NADH and NADPH, causing energetic deficits and oxidative stress. This pathway is summarised in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>.<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Pathways in reactive oxygen species (ROS) production. Electrons &#x02018;leaking&#x02019; across the electron transport chain produce superoxide (O<sub>2</sub><sup>&#x02212;</sup>), which is converted to hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) by superoxide dysmutase (SOD), both of which are reactive oxygen species. Hydrogen peroxide may be converted to water by using NADPH as an electron donor. NADPH is formed from NADH via nicotinamide nucleotide transhydrogenase (NNT), so a reduction in NADH availability due to increased ATP demand will reduce antioxidant capacity within the cell</p></caption><graphic xlink:href="10557_2024_7582_Fig4_HTML" id="MO4"/></fig></p><p id="Par34">ROS accumulation has been reported in cardiomyopathies and heart failure, although the direct cellular mechanisms leading to its production have not been fully elucidated: there may be multiple mechanisms and they may vary between types of heart failure. Mechanical stretch appears to directly activate ROS production via the Rac1-ROS pathway [<xref ref-type="bibr" rid="CR74">74</xref>] and direct stretch on heart cells causes activation of NOX2 leading to ROS generation in a mechanochemical manner which is microtubule dependent, referred to as X-ROS signalling [<xref ref-type="bibr" rid="CR75">75</xref>]. X-ROS signalling is responsible for experimentally inducing arrhythmogenic calcium waves in Duchenne muscular dystrophy cells [<xref ref-type="bibr" rid="CR76">76</xref>] and high levels of mechanical stress cause SERCA inactivation via peroxynitrite-mediated nitration [<xref ref-type="bibr" rid="CR77">77</xref>], leading to calcium load.</p><p id="Par35">As well as in CaMKII activation, ROS activate hypertrophy signalling kinases [<xref ref-type="bibr" rid="CR78">78</xref>], cause damage to mitochondrial [<xref ref-type="bibr" rid="CR79">79</xref>] and cellular DNA [<xref ref-type="bibr" rid="CR80">80</xref>], cause apoptosis [<xref ref-type="bibr" rid="CR81">81</xref>], activate secretion of matrix metalloproteases [<xref ref-type="bibr" rid="CR80">80</xref>] and increase open possibility of ryanodine receptors, thus producing arrhythmia [<xref ref-type="bibr" rid="CR82">82</xref>]. ROS can also beget further ROS production in a vicious cycle [<xref ref-type="bibr" rid="CR83">83</xref>].</p><p id="Par36">However, ROS has regulatory functions in other tissues and may also have some in the heart [<xref ref-type="bibr" rid="CR51">51</xref>] so it should not be considered to be solely damaging. Nonetheless, mitochondrial ROS are causally related to HF progression in a variety of animal models [<xref ref-type="bibr" rid="CR72">72</xref>].</p></sec><sec id="Sec18"><title>Mitochondrial Permeability Transition Pore</title><p id="Par37">The mitochondrial permeability transition pore (MPTP) is a key mechanism for mediating cardiac dysfunction and cell death: when it opens, it allows passages of solutes up to 1.5&#x000a0;kDa in size [<xref ref-type="bibr" rid="CR84">84</xref>], resulting in inner membrane potential collapse, respiratory chain uncoupling and hence halting mitochrondrial ATP synthesis. Eventually, mitochondrial swelling, rupture and necrotic cell death occur [<xref ref-type="bibr" rid="CR85">85</xref>]. It is primarily triggered by calcium levels within the mitochondrial matrix; however, oxidative stress, adenine nucleotide depletion, elevated phosphate and pH/mitochondrial depolarisation will also open it, and other divalent cations (e.g. magnesium) will inhibit its opening [<xref ref-type="bibr" rid="CR86">86</xref>]. Despite much work, which protein (or proteins) make up the MPTP is still uncertain, with cyclophilin-D, adenine nucleotide translocase, mitochondrial phosphate carrier, F<sub>1</sub>F<sub>0</sub> ATP synthase and the voltage-dependent anion channel all proposed [<xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR87">87</xref>].</p><p id="Par38">The MPTP has some physiological functions and is involved in ROS signalling (producing &#x02018;flashes&#x02019; of superoxide [<xref ref-type="bibr" rid="CR88">88</xref>]), cardiomyocyte development [<xref ref-type="bibr" rid="CR89">89</xref>] and mitochondrial calcium efflux. Transient openings of the MPTP have been proposed as a mechanism to reduce calcium concentrations within the mitochondrion when in sustained calcium overload [<xref ref-type="bibr" rid="CR90">90</xref>].</p><p id="Par39">It is easy to see how ischaemia will lead to MPTP opening, as ATP levels dissipate, ROS are produced and calcium levels climb [<xref ref-type="bibr" rid="CR91">91</xref>]. In addition, the MPTP remains open in reperfusion and is mechanistic in ischaemia&#x02013;reperfusion injury [<xref ref-type="bibr" rid="CR92">92</xref>], while playing a role in ischaemic preconditioning [<xref ref-type="bibr" rid="CR93">93</xref>].</p><p id="Par40">As calcium dysregulation, ATP depletion and ROS production are all present in heart failure, it has been hypothesised that MPTP is involved in HF progression [<xref ref-type="bibr" rid="CR87">87</xref>]. CypD-deficient mice were protected against cardiomyopathy induced by calcium overload [<xref ref-type="bibr" rid="CR94">94</xref>], but display increased hypertrophy and mortality in response to pressure overload [<xref ref-type="bibr" rid="CR95">95</xref>], perhaps illustrating some of the protective functions of MPTP.</p></sec><sec id="Sec19"><title>Senescence</title><p id="Par41">Senescence is usually considered a state of cell cycle arrest; however, as cardiomyocytes are terminally differentiated, they must be considered differently [<xref ref-type="bibr" rid="CR96">96</xref>]. Senescent cardiomyocytes exhibit functional alterations (dysregulated contraction, irregular shortening, elevated pacing frequency), structural alterations (enlarged size, mitochondrial dysfunction, shortened telomeres) and production of factors affecting neighbouring cells (SASP: senescence-associated secreting phenotype) [<xref ref-type="bibr" rid="CR97">97</xref>].</p><p id="Par42">Mitochondrial dysfunction occurs&#x000a0;in senescence, in response to p53 activation [<xref ref-type="bibr" rid="CR69">69</xref>] and downstream signalling from hypoxia [<xref ref-type="bibr" rid="CR98">98</xref>].</p><p id="Par43">ROS are implicated in the pathophysiology of senescence, causing DNA damage. Telomere shortening being the commonest feature, which has been shown to drive a senescent-type phenotype [<xref ref-type="bibr" rid="CR99">99</xref>], while DNA damage links to NAD&#x02009;+&#x02009;depletion and consequent energy loss via PARP1 [<xref ref-type="bibr" rid="CR100">100</xref>].</p></sec></sec><sec id="Sec20"><title>Areas for Future Work</title><sec id="Sec21"><title>Mitochondrial Damage-Associated Molecular Patterns</title><p id="Par44">Damaged tissue releases DAMPs (damage-associated molecular patterns), which act on immune cells but also a wide range of tissues including cardiomyocytes, cardiac fibroblasts and cardiac endothelial cells. Mitochondrial DAMPs (mDAMPs) are those released from within mitochondria, including mitochondrial DNA, N-formyl peptides, cardiolipin, mitochondrial transcription factor A (TFAM), ATP, reactive oxygen species (ROS), succinate and cytochrome C [<xref ref-type="bibr" rid="CR101">101</xref>]. These may be released by damaged or stressed mitochondria into the cytosol, or from necrotic cells into the extracellular space. Cytochrome C, mitochondrial DNA and succinate have been shown to correlate with markers of myocardial injury such as troponin or myocardial oedema [<xref ref-type="bibr" rid="CR101">101</xref>] and activate healthy PBMCs [<xref ref-type="bibr" rid="CR102">102</xref>]. Mitochondrial DNA [<xref ref-type="bibr" rid="CR103">103</xref>] and ER stress [<xref ref-type="bibr" rid="CR104">104</xref>] activate the cGAS-STING pathway, which is involved in myocyte senescence [<xref ref-type="bibr" rid="CR105">105</xref>], as well as activating NF-kB and IRF-3 pathways, leading to TGF-B1 production and fibrosis [<xref ref-type="bibr" rid="CR106">106</xref>].</p><p id="Par45">Mitochondrial DNA escaping autophagy has been shown to cause TLR9-mediated inflammatory responses resulting in infiltration by inflammatory cells and inflammatory cytokine expression leading to inflammation and cardiac chamber dilation in mice [<xref ref-type="bibr" rid="CR107">107</xref>].</p></sec></sec><sec id="Sec22"><title>Conclusions</title><p id="Par46">Sustained high cardiac workload sets up a vicious cycle of mitochondrial stress and calcium mishandling. Reduced calcium entry into mitochondria worsens the mismatch between energy supply and demand and oxidative stress results in production of reactive oxygen species, causing CaMKII activation and further deleterious changes to calcium handling. Beta-adrenoreceptor activation feeds directly into calcium mishandling and indirectly via CaMKII activation. Production of ROS and mitochondrial DAMPs causes cellular and tissue level damage. These processes link increased cardiac workload to the progression of heart failure (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Overall schematic linking increased mechanical work to damaging processes causing heart failure progression. Blue boxes indicate adaptive processes and red boxes maladaptive processes</p></caption><graphic xlink:href="10557_2024_7582_Fig5_HTML" id="MO5"/></fig></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author Contribution</title><p>WW drafted the manuscript with input from PMA and JM. AL and OR reviewed and made further contributions.</p></notes><notes notes-type="data-availability"><title>Data Availability</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Code Availability</title><p>Not applicable.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics Approval</title><p id="Par47">Not applicable.</p></notes><notes id="FPar2"><title>Consent to Participate</title><p id="Par48">Not applicable.</p></notes><notes id="FPar3"><title>Consent for Publication</title><p id="Par49">Not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Conflict of Interest</title><p id="Par50">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Kehat</surname><given-names>I</given-names></name><name><surname>Molkentin</surname><given-names>JD</given-names></name></person-group><article-title>Molecular pathways underlying cardiac remodeling during pathophysiological stimulation</article-title><source>Circulation</source><year>2010</year><volume>122</volume><issue>25</issue><fpage>2727</fpage><lpage>2735</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.942268</pub-id><pub-id pub-id-type="pmid">21173361</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Kehat I, Molkentin JD. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation. 2010;122(25):2727&#x02013;35.<pub-id pub-id-type="pmid">21173361</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Tanai</surname><given-names>E</given-names></name><name><surname>Frantz</surname><given-names>S</given-names></name></person-group><article-title>Pathophysiology of heart failure</article-title><source>Compr Physiol</source><year>2011</year><volume>6</volume><issue>1</issue><fpage>187</fpage><lpage>214</lpage></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Tanai E, Frantz S. Pathophysiology of heart failure. Compr Physiol. 2011;6(1):187&#x02013;214.</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Pitoulis</surname><given-names>FG</given-names></name><name><surname>Terracciano</surname><given-names>CM</given-names></name></person-group><article-title>Heart plasticity in response to pressure-and volume-overload: a review of findings in compensated and decompensated phenotypes</article-title><source>Front Physiol</source><year>2020</year><volume>11</volume><fpage>92</fpage><pub-id pub-id-type="doi">10.3389/fphys.2020.00092</pub-id><pub-id pub-id-type="pmid">32116796</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Pitoulis FG, Terracciano CM. Heart plasticity in response to pressure-and volume-overload: a review of findings in compensated and decompensated phenotypes. Front Physiol. 2020;11:92.<pub-id pub-id-type="pmid">32116796</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Dorn</surname><given-names>GW</given-names></name></person-group><article-title>The fuzzy logic of physiological cardiac hypertrophy</article-title><source>Hypertension</source><year>2007</year><volume>49</volume><issue>5</issue><fpage>962</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.106.079426</pub-id><pub-id pub-id-type="pmid">17389260</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Dorn GW. The fuzzy logic of physiological cardiac hypertrophy. Hypertension. 2007;49(5):962&#x02013;70.<pub-id pub-id-type="pmid">17389260</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Khalafbeigui</surname><given-names>F</given-names></name><name><surname>Suga</surname><given-names>H</given-names></name><name><surname>Sagawa</surname><given-names>K</given-names></name></person-group><article-title>Left ventricular systolic pressure-volume area correlates with oxygen consumption</article-title><source>Am J Physiol</source><year>1979</year><volume>237</volume><issue>5</issue><fpage>H566</fpage><lpage>H569</lpage><pub-id pub-id-type="pmid">495762</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Khalafbeigui F, Suga H, Sagawa K. Left ventricular systolic pressure-volume area correlates with oxygen consumption. Am J Physiol. 1979;237(5):H566&#x02013;9.<pub-id pub-id-type="pmid">495762</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Suga</surname><given-names>H</given-names></name></person-group><article-title>Total mechanical energy of a ventricle model and cardiac oxygen consumption</article-title><source>Am J Physiol-Heart Circ Physiol</source><year>1979</year><volume>236</volume><issue>3</issue><fpage>H498</fpage><lpage>H505</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.1979.236.3.H498</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Suga H. Total mechanical energy of a ventricle model and cardiac oxygen consumption. Am J Physiol-Heart Circ Physiol. 1979;236(3):H498&#x02013;505.</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Suga</surname><given-names>H</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Shirahata</surname><given-names>M</given-names></name></person-group><article-title>Ventricular systolic pressure-volume area as predictor of cardiac oxygen consumption</article-title><source>Am J Physiol</source><year>1981</year><volume>240</volume><issue>1</issue><fpage>H39</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">7457620</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Suga H, Hayashi T, Shirahata M. Ventricular systolic pressure-volume area as predictor of cardiac oxygen consumption. Am J Physiol. 1981;240(1):H39-44.<pub-id pub-id-type="pmid">7457620</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Ohgoshi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Sensitivities of cardiac O2 consumption and contractility to catecholamines in dogs</article-title><source>Am J Physiol-Heart Circ Physiol</source><year>1991</year><volume>261</volume><issue>1</issue><fpage>H196</fpage><lpage>H205</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.1991.261.1.H196</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Ohgoshi Y, et al. Sensitivities of cardiac O2 consumption and contractility to catecholamines in dogs. Am J Physiol-Heart Circ Physiol. 1991;261(1):H196&#x02013;205.</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Suga</surname><given-names>H</given-names></name></person-group><article-title>Ventricular energetics</article-title><source>Physiol Rev</source><year>1990</year><volume>70</volume><issue>2</issue><fpage>247</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1152/physrev.1990.70.2.247</pub-id><pub-id pub-id-type="pmid">2181496</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Suga H. Ventricular energetics. Physiol Rev. 1990;70(2):247&#x02013;77.<pub-id pub-id-type="pmid">2181496</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhoff</surname><given-names>D</given-names></name><name><surname>Sagawa</surname><given-names>K</given-names></name></person-group><article-title>Ventricular efficiency predicted by an analytical model</article-title><source>Am J Physiol-Reg, Integr Comp Physiol</source><year>1986</year><volume>250</volume><issue>6</issue><fpage>R1021</fpage><lpage>R1027</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.1986.250.6.R1021</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Burkhoff D, Sagawa K. Ventricular efficiency predicted by an analytical model. Am J Physiol-Reg, Integr Comp Physiol. 1986;250(6):R1021&#x02013;7.</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Asanoi</surname><given-names>H</given-names></name><name><surname>Sasayama</surname><given-names>S</given-names></name><name><surname>Kameyama</surname><given-names>T</given-names></name></person-group><article-title>Ventriculoarterial coupling in normal and failing heart in humans</article-title><source>Circ Res</source><year>1989</year><volume>65</volume><issue>2</issue><fpage>483</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1161/01.RES.65.2.483</pub-id><pub-id pub-id-type="pmid">2752553</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Asanoi H, Sasayama S, Kameyama T. Ventriculoarterial coupling in normal and failing heart in humans. Circ Res. 1989;65(2):483&#x02013;93.<pub-id pub-id-type="pmid">2752553</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Kyriacou</surname><given-names>A</given-names></name><etal/></person-group><article-title>Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally</article-title><source>Int J Cardiol</source><year>2014</year><volume>171</volume><issue>2</issue><fpage>144</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2013.10.026</pub-id><pub-id pub-id-type="pmid">24332598</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Kyriacou A, et al. Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally. Int J Cardiol. 2014;171(2):144&#x02013;52.<pub-id pub-id-type="pmid">24332598</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Schreuder</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Acute decrease of left ventricular mechanical dyssynchrony and improvement of contractile state and energy efficiency after left ventricular restoration</article-title><source>J Thorac Cardiovasc Surg</source><year>2005</year><volume>129</volume><issue>1</issue><fpage>138</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2004.03.057</pub-id><pub-id pub-id-type="pmid">15632835</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Schreuder JJ, et al. Acute decrease of left ventricular mechanical dyssynchrony and improvement of contractile state and energy efficiency after left ventricular restoration. J Thorac Cardiovasc Surg. 2005;129(1):138&#x02013;45.<pub-id pub-id-type="pmid">15632835</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>WD</given-names></name><etal/></person-group><article-title>Myocardial energy response to glyceryl trinitrate: physiology revisited</article-title><source>Front Physiol</source><year>2021</year><volume>12</volume><fpage>790525</fpage><pub-id pub-id-type="doi">10.3389/fphys.2021.790525</pub-id><pub-id pub-id-type="pmid">35035360</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Watson WD, et al. Myocardial energy response to glyceryl trinitrate: physiology revisited. Front Physiol. 2021;12: 790525.<pub-id pub-id-type="pmid">35035360</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>JV</given-names></name><etal/></person-group><article-title>Right ventricular myocardial energetic model for evaluating right heart function in pulmonary arterial hypertension</article-title><source>Physiol Rep</source><year>2022</year><volume>10</volume><issue>10</issue><fpage>e15136</fpage><pub-id pub-id-type="doi">10.14814/phy2.15136</pub-id><pub-id pub-id-type="pmid">35582996</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Scott JV, et al. Right ventricular myocardial energetic model for evaluating right heart function in pulmonary arterial hypertension. Physiol Rep. 2022;10(10): e15136.<pub-id pub-id-type="pmid">35582996</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Pironet</surname><given-names>A</given-names></name><etal/></person-group><article-title>Simulation of left atrial function using a multi-scale model of the cardiovascular system</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><issue>6</issue><fpage>e65146</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0065146</pub-id><pub-id pub-id-type="pmid">23755183</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Pironet A, et al. Simulation of left atrial function using a multi-scale model of the cardiovascular system. PLoS ONE. 2013;8(6): e65146.<pub-id pub-id-type="pmid">23755183</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Bertero</surname><given-names>E</given-names></name><name><surname>Maack</surname><given-names>C</given-names></name></person-group><article-title>Metabolic remodelling in heart failure</article-title><source>Nat Rev Cardiol</source><year>2018</year><volume>15</volume><issue>8</issue><fpage>457</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1038/s41569-018-0044-6</pub-id><pub-id pub-id-type="pmid">29915254</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Bertero E, Maack C. Metabolic remodelling in heart failure. Nat Rev Cardiol. 2018;15(8):457&#x02013;70.<pub-id pub-id-type="pmid">29915254</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>WC</given-names></name><name><surname>Recchia</surname><given-names>FA</given-names></name><name><surname>Lopaschuk</surname><given-names>GD</given-names></name></person-group><article-title>Myocardial substrate metabolism in the normal and failing heart</article-title><source>Physiol Rev</source><year>2005</year><volume>85</volume><issue>3</issue><fpage>1093</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1152/physrev.00006.2004</pub-id><pub-id pub-id-type="pmid">15987803</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85(3):1093&#x02013;129.<pub-id pub-id-type="pmid">15987803</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Karwi</surname><given-names>QG</given-names></name><etal/></person-group><article-title>Loss of metabolic flexibility in the failing heart</article-title><source>Front Cardiovasc Med</source><year>2018</year><volume>5</volume><fpage>68</fpage><pub-id pub-id-type="doi">10.3389/fcvm.2018.00068</pub-id><pub-id pub-id-type="pmid">29928647</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Karwi QG, et al. Loss of metabolic flexibility in the failing heart. Front Cardiovasc Med. 2018;5:68.<pub-id pub-id-type="pmid">29928647</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Relation between work and phosphate metabolite in the in vivo paced mammalian heart</article-title><source>Science</source><year>1986</year><volume>232</volume><issue>4754</issue><fpage>1121</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1126/science.3704638</pub-id><pub-id pub-id-type="pmid">3704638</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Balaban RS, et al. Relation between work and phosphate metabolite in the in vivo paced mammalian heart. Science. 1986;232(4754):1121&#x02013;3.<pub-id pub-id-type="pmid">3704638</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Naumova</surname><given-names>AV</given-names></name><name><surname>Weiss</surname><given-names>RG</given-names></name><name><surname>Chacko</surname><given-names>VP</given-names></name></person-group><article-title>Regulation of murine myocardial energy metabolism during adrenergic stress studied by in vivo 31P NMR spectroscopy</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2003</year><volume>285</volume><issue>5</issue><fpage>H1976</fpage><lpage>H1979</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00474.2003</pub-id><pub-id pub-id-type="pmid">12881208</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Naumova AV, Weiss RG, Chacko VP. Regulation of murine myocardial energy metabolism during adrenergic stress studied by in vivo 31P NMR spectroscopy. Am J Physiol Heart Circ Physiol. 2003;285(5):H1976&#x02013;9.<pub-id pub-id-type="pmid">12881208</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>S</given-names></name><etal/></person-group><article-title>Metabolic response of the human heart to inotropic stimulation: in vivo phosphorus-31 studies of normal and cardiomyopathic myocardium</article-title><source>Magn Reson Med</source><year>1992</year><volume>25</volume><issue>2</issue><fpage>260</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1002/mrm.1910250205</pub-id><pub-id pub-id-type="pmid">1614310</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Schaefer S, et al. Metabolic response of the human heart to inotropic stimulation: in vivo phosphorus-31 studies of normal and cardiomyopathic myocardium. Magn Reson Med. 1992;25(2):260&#x02013;72.<pub-id pub-id-type="pmid">1614310</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Saks</surname><given-names>V</given-names></name><etal/></person-group><article-title>Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands</article-title><source>J Physiol</source><year>2006</year><volume>577</volume><issue>Pt 3</issue><fpage>769</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2006.120584</pub-id><pub-id pub-id-type="pmid">17008367</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Saks V, et al. Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands. J Physiol. 2006;577(Pt 3):769&#x02013;77.<pub-id pub-id-type="pmid">17008367</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Guzun</surname><given-names>R</given-names></name><etal/></person-group><article-title>Modular organization of cardiac energy metabolism: energy conversion, transfer and feedback regulation</article-title><source>Acta Physiol</source><year>2015</year><volume>213</volume><issue>1</issue><fpage>84</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1111/apha.12287</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Guzun R, et al. Modular organization of cardiac energy metabolism: energy conversion, transfer and feedback regulation. Acta Physiol. 2015;213(1):84&#x02013;106.</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Bose</surname><given-names>S</given-names></name><etal/></person-group><article-title>Metabolic network control of oxidative phosphorylation: multiple roles of inorganic phosphate</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><issue>40</issue><fpage>39155</fpage><lpage>39165</lpage><pub-id pub-id-type="doi">10.1074/jbc.M306409200</pub-id><pub-id pub-id-type="pmid">12871940</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Bose S, et al. Metabolic network control of oxidative phosphorylation: multiple roles of inorganic phosphate. J Biol Chem. 2003;278(40):39155&#x02013;65.<pub-id pub-id-type="pmid">12871940</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Saks</surname><given-names>V</given-names></name><etal/></person-group><article-title>Cardiac system bioenergetics: metabolic basis of the Frank-Starling law</article-title><source>J Physiol</source><year>2006</year><volume>571</volume><issue>2</issue><fpage>253</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2005.101444</pub-id><pub-id pub-id-type="pmid">16410283</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Saks V, et al. Cardiac system bioenergetics: metabolic basis of the Frank-Starling law. J Physiol. 2006;571(2):253&#x02013;73.<pub-id pub-id-type="pmid">16410283</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Arad</surname><given-names>M</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name></person-group><article-title>AMP-activated protein kinase in the heart</article-title><source>Circ Res</source><year>2007</year><volume>100</volume><issue>4</issue><fpage>474</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000258446.23525.37</pub-id><pub-id pub-id-type="pmid">17332438</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Arad M, Seidman CE, Seidman JG. AMP-activated protein kinase in the heart. Circ Res. 2007;100(4):474&#x02013;88.<pub-id pub-id-type="pmid">17332438</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Hue</surname><given-names>L</given-names></name><name><surname>Taegtmeyer</surname><given-names>H</given-names></name></person-group><article-title>The Randle cycle revisited: a new head for an old hat</article-title><source>Am J Physiol-Endocrinol Metab</source><year>2009</year><volume>297</volume><issue>3</issue><fpage>E578</fpage><lpage>E591</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00093.2009</pub-id><pub-id pub-id-type="pmid">19531645</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol-Endocrinol Metab. 2009;297(3):E578&#x02013;91.<pub-id pub-id-type="pmid">19531645</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Role of calcium in metabolic signaling between cardiac sarcoplasmic reticulum and mitochondria in vitro</article-title><source>Am J Physiol Cell Physiol</source><year>2003</year><volume>284</volume><issue>2</issue><fpage>C285</fpage><lpage>C293</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00129.2002</pub-id><pub-id pub-id-type="pmid">12529248</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Balaban RS, et al. Role of calcium in metabolic signaling between cardiac sarcoplasmic reticulum and mitochondria in vitro. Am J Physiol Cell Physiol. 2003;284(2):C285&#x02013;93.<pub-id pub-id-type="pmid">12529248</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Denton</surname><given-names>RM</given-names></name><name><surname>McCormack</surname><given-names>JG</given-names></name></person-group><article-title>On the role of the calcium transport cycle in heart and other mammalian mitochondria</article-title><source>FEBS Lett</source><year>1980</year><volume>119</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(80)80986-0</pub-id><pub-id pub-id-type="pmid">7000543</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Denton RM, McCormack JG. On the role of the calcium transport cycle in heart and other mammalian mitochondria. FEBS Lett. 1980;119(1):1&#x02013;8.<pub-id pub-id-type="pmid">7000543</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Territo</surname><given-names>PR</given-names></name><etal/></person-group><article-title>Ca2+ activation of heart mitochondrial oxidative phosphorylation: role of the F0/F1-ATPase</article-title><source>Am J Physiol Cell Physiol</source><year>2000</year><volume>278</volume><issue>2</issue><fpage>C423</fpage><lpage>C435</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.2000.278.2.C423</pub-id><pub-id pub-id-type="pmid">10666039</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Territo PR, et al. Ca2+ activation of heart mitochondrial oxidative phosphorylation: role of the F0/F1-ATPase. Am J Physiol Cell Physiol. 2000;278(2):C423&#x02013;35.<pub-id pub-id-type="pmid">10666039</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Angin</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Calcium signaling recruits substrate transporters GLUT4 and CD36 to the sarcolemma without increasing cardiac substrate uptake</article-title><source>Am J Physiol-Endocrinol Metab</source><year>2014</year><volume>307</volume><issue>2</issue><fpage>E225</fpage><lpage>E236</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00655.2013</pub-id><pub-id pub-id-type="pmid">24895286</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Angin Y, et al. Calcium signaling recruits substrate transporters GLUT4 and CD36 to the sarcolemma without increasing cardiac substrate uptake. Am J Physiol-Endocrinol Metab. 2014;307(2):E225&#x02013;36.<pub-id pub-id-type="pmid">24895286</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Brandes</surname><given-names>R</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name></person-group><article-title>Simultaneous measurements of mitochondrial NADH and Ca2+ during increased work in intact rat heart trabeculae</article-title><source>Biophys J </source><year>2002</year><volume>83</volume><issue>2</issue><fpage>587</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(02)75194-1</pub-id><pub-id pub-id-type="pmid">12124250</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Brandes R, Bers DM. Simultaneous measurements of mitochondrial NADH and Ca2+ during increased work in intact rat heart trabeculae. Biophys J. 2002;83(2):587&#x02013;604.<pub-id pub-id-type="pmid">12124250</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Cortassa</surname><given-names>S</given-names></name><etal/></person-group><article-title>Control and regulation of mitochondrial energetics in an integrated model of cardiomyocyte function</article-title><source>Biophys J </source><year>2009</year><volume>96</volume><issue>6</issue><fpage>2466</fpage><lpage>2478</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2008.12.3893</pub-id><pub-id pub-id-type="pmid">19289071</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Cortassa S, et al. Control and regulation of mitochondrial energetics in an integrated model of cardiomyocyte function. Biophys J. 2009;96(6):2466&#x02013;78.<pub-id pub-id-type="pmid">19289071</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Kohlhaas</surname><given-names>M</given-names></name><name><surname>Maack</surname><given-names>C</given-names></name></person-group><article-title>Adverse bioenergetic consequences of Na+-Ca2+ exchanger&#x02013;mediated Ca2+ influx in cardiac myocytes</article-title><source>Circulation</source><year>2010</year><volume>122</volume><issue>22</issue><fpage>2273</fpage><lpage>2280</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.968057</pub-id><pub-id pub-id-type="pmid">21098439</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Kohlhaas M, Maack C. Adverse bioenergetic consequences of Na+-Ca2+ exchanger&#x02013;mediated Ca2+ influx in cardiac myocytes. Circulation. 2010;122(22):2273&#x02013;80.<pub-id pub-id-type="pmid">21098439</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>X</given-names></name><etal/></person-group><article-title>The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter</article-title><source>Nat Cell Biol</source><year>2013</year><volume>15</volume><issue>12</issue><fpage>1464</fpage><lpage>1472</lpage><pub-id pub-id-type="doi">10.1038/ncb2868</pub-id><pub-id pub-id-type="pmid">24212091</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Pan X, et al. The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter. Nat Cell Biol. 2013;15(12):1464&#x02013;72.<pub-id pub-id-type="pmid">24212091</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The mitochondrial uniporter controls fight or flight heart rate increases</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><issue>1</issue><fpage>6081</fpage><pub-id pub-id-type="doi">10.1038/ncomms7081</pub-id><pub-id pub-id-type="pmid">25603276</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Wu Y, et al. The mitochondrial uniporter controls fight or flight heart rate increases. Nat Commun. 2015;6(1):6081.<pub-id pub-id-type="pmid">25603276</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Palty</surname><given-names>R</given-names></name><etal/></person-group><article-title>NCLX is an essential component of mitochondrial Na+/Ca2+ exchange</article-title><source>Proc Natl Acad Sci</source><year>2010</year><volume>107</volume><issue>1</issue><fpage>436</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1073/pnas.0908099107</pub-id><pub-id pub-id-type="pmid">20018762</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Palty R, et al. NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc Natl Acad Sci. 2010;107(1):436&#x02013;41.<pub-id pub-id-type="pmid">20018762</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>H</given-names></name><etal/></person-group><article-title>Mechanotranduction pathways in the regulation of mitochondrial homeostasis in cardiomyocytes</article-title><source>Frontiers in cell and developmental biology</source><year>2021</year><volume>8</volume><fpage>625089</fpage><pub-id pub-id-type="doi">10.3389/fcell.2020.625089</pub-id><pub-id pub-id-type="pmid">33553165</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Liao H, et al. Mechanotranduction pathways in the regulation of mitochondrial homeostasis in cardiomyocytes. Frontiers in cell and developmental biology. 2021;8: 625089.<pub-id pub-id-type="pmid">33553165</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname><given-names>RC</given-names></name><etal/></person-group><article-title>Mechanotransduction in cardiac hypertrophy and failure</article-title><source>Circ Res</source><year>2015</year><volume>116</volume><issue>8</issue><fpage>1462</fpage><lpage>1476</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.304937</pub-id><pub-id pub-id-type="pmid">25858069</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Lyon RC, et al. Mechanotransduction in cardiac hypertrophy and failure. Circ Res. 2015;116(8):1462&#x02013;76.<pub-id pub-id-type="pmid">25858069</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Iribe</surname><given-names>G</given-names></name><etal/></person-group><article-title>Axial stretch of rat single ventricular cardiomyocytes causes an acute and transient increase in Ca2+ spark rate</article-title><source>Circ Res</source><year>2009</year><volume>104</volume><issue>6</issue><fpage>787</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.193334</pub-id><pub-id pub-id-type="pmid">19197074</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Iribe G, et al. Axial stretch of rat single ventricular cardiomyocytes causes an acute and transient increase in Ca2+ spark rate. Circ Res. 2009;104(6):787&#x02013;95.<pub-id pub-id-type="pmid">19197074</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Schulman</surname><given-names>H</given-names></name><name><surname>Anderson</surname><given-names>ME</given-names></name></person-group><article-title>Ca2+/calmodulin-dependent protein kinase II in heart failure</article-title><source>Drug Discovery Today: Disease Mech</source><year>2010</year><volume>7</volume><issue>2</issue><fpage>e117</fpage><lpage>e122</lpage><pub-id pub-id-type="doi">10.1016/j.ddmec.2010.07.005</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Schulman H, Anderson ME. Ca2+/calmodulin-dependent protein kinase II in heart failure. Drug Discovery Today: Disease Mech. 2010;7(2):e117&#x02013;22.</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhoff</surname><given-names>D</given-names></name><etal/></person-group><article-title>Influence of metabolic substrate on rat heart function and metabolism at different coronary flows</article-title><source>Am J Physiol</source><year>1991</year><volume>261</volume><issue>3 Pt 2</issue><fpage>H741</fpage><lpage>H750</lpage><pub-id pub-id-type="pmid">1887921</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Burkhoff D, et al. Influence of metabolic substrate on rat heart function and metabolism at different coronary flows. Am J Physiol. 1991;261(3 Pt 2):H741&#x02013;50.<pub-id pub-id-type="pmid">1887921</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><etal/></person-group><article-title>The &#x003b4;C isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure</article-title><source>Circ Res</source><year>2003</year><volume>92</volume><issue>8</issue><fpage>912</fpage><lpage>919</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000069686.31472.C5</pub-id><pub-id pub-id-type="pmid">12676814</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Zhang T, et al. The &#x003b4;C isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res. 2003;92(8):912&#x02013;9.<pub-id pub-id-type="pmid">12676814</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Dzhura</surname><given-names>I</given-names></name><etal/></person-group><article-title>Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels</article-title><source>Nat Cell Biol</source><year>2000</year><volume>2</volume><issue>3</issue><fpage>173</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1038/35004052</pub-id><pub-id pub-id-type="pmid">10707089</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Dzhura I, et al. Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat Cell Biol. 2000;2(3):173&#x02013;7.<pub-id pub-id-type="pmid">10707089</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>LS</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name></person-group><article-title>Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond</article-title><source>J Mol Cell Cardiol</source><year>2002</year><volume>34</volume><issue>8</issue><fpage>919</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1006/jmcc.2002.2038</pub-id><pub-id pub-id-type="pmid">12234763</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Maier LS, Bers DM. Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J Mol Cell Cardiol. 2002;34(8):919&#x02013;39.<pub-id pub-id-type="pmid">12234763</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>DeSantiago</surname><given-names>J</given-names></name><name><surname>Maier</surname><given-names>LS</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name></person-group><article-title>Frequency-dependent acceleration of relaxation in the heart depends on CaMKII, but not phospholamban</article-title><source>J Mol Cell Cardiol</source><year>2002</year><volume>34</volume><issue>8</issue><fpage>975</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1006/jmcc.2002.2034</pub-id><pub-id pub-id-type="pmid">12234767</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">DeSantiago J, Maier LS, Bers DM. Frequency-dependent acceleration of relaxation in the heart depends on CaMKII, but not phospholamban. J Mol Cell Cardiol. 2002;34(8):975&#x02013;84.<pub-id pub-id-type="pmid">12234767</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Kohlhaas</surname><given-names>M</given-names></name><name><surname>Maack</surname><given-names>C</given-names></name></person-group><article-title>Calcium release microdomains and mitochondria</article-title><source>Cardiovasc Res</source><year>2013</year><volume>98</volume><issue>2</issue><fpage>259</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvt032</pub-id><pub-id pub-id-type="pmid">23417042</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Kohlhaas M, Maack C. Calcium release microdomains and mitochondria. Cardiovasc Res. 2013;98(2):259&#x02013;68.<pub-id pub-id-type="pmid">23417042</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>O'Rourke</surname><given-names>B</given-names></name></person-group><article-title>Enhancing mitochondrial Ca2+ uptake in myocytes from failing hearts restores energy supply and demand matching</article-title><source>Circ Res</source><year>2008</year><volume>103</volume><issue>3</issue><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.175919</pub-id><pub-id pub-id-type="pmid">18599868</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Liu T, O&#x02019;Rourke B. Enhancing mitochondrial Ca2+ uptake in myocytes from failing hearts restores energy supply and demand matching. Circ Res. 2008;103(3):279&#x02013;88.<pub-id pub-id-type="pmid">18599868</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>XD</given-names></name><etal/></person-group><article-title>Role of Ca2+ signaling in initiation of stretch-induced apoptosis in neonatal heart cells</article-title><source>Biochem Biophys Res Commun</source><year>2003</year><volume>310</volume><issue>2</issue><fpage>405</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2003.09.023</pub-id><pub-id pub-id-type="pmid">14521925</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Liao XD, et al. Role of Ca2+ signaling in initiation of stretch-induced apoptosis in neonatal heart cells. Biochem Biophys Res Commun. 2003;310(2):405&#x02013;11.<pub-id pub-id-type="pmid">14521925</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>JC</given-names></name></person-group><article-title>Mitochondrial calcium and reactive oxygen species in cardiovascular disease</article-title><source>Cardiovasc Res</source><year>2023</year><volume>119</volume><issue>5</issue><fpage>1105</fpage><lpage>1116</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvac134</pub-id><pub-id pub-id-type="pmid">35986915</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Murphy E, Liu JC. Mitochondrial calcium and reactive oxygen species in cardiovascular disease. Cardiovasc Res. 2023;119(5):1105&#x02013;16.<pub-id pub-id-type="pmid">35986915</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Rasola</surname><given-names>A</given-names></name><name><surname>Bernardi</surname><given-names>P</given-names></name></person-group><article-title>Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis</article-title><source>Cell Calcium</source><year>2011</year><volume>50</volume><issue>3</issue><fpage>222</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2011.04.007</pub-id><pub-id pub-id-type="pmid">21601280</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Rasola A, Bernardi P. Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis. Cell Calcium. 2011;50(3):222&#x02013;33.<pub-id pub-id-type="pmid">21601280</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Mangmool</surname><given-names>S</given-names></name><name><surname>Shukla</surname><given-names>AK</given-names></name><name><surname>Rockman</surname><given-names>HA</given-names></name></person-group><article-title>&#x003b2;-Arrestin&#x02013;dependent activation of Ca2+/calmodulin kinase II after &#x003b2;1&#x02013;adrenergic receptor stimulation</article-title><source>J Cell Biol</source><year>2010</year><volume>189</volume><issue>3</issue><fpage>573</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1083/jcb.200911047</pub-id><pub-id pub-id-type="pmid">20421423</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Mangmool S, Shukla AK, Rockman HA. &#x003b2;-Arrestin&#x02013;dependent activation of Ca2+/calmodulin kinase II after &#x003b2;1&#x02013;adrenergic receptor stimulation. J Cell Biol. 2010;189(3):573&#x02013;87.<pub-id pub-id-type="pmid">20421423</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>W-Z</given-names></name><etal/></person-group><article-title>Linkage of &#x003b2; 1-adrenergic stimulation to apoptotic heart cell death through protein kinase A&#x02013;independent activation of Ca 2+/calmodulin kinase II</article-title><source>J Clin Investig</source><year>2003</year><volume>111</volume><issue>5</issue><fpage>617</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1172/JCI200316326</pub-id><pub-id pub-id-type="pmid">12618516</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Zhu W-Z, et al. Linkage of &#x003b2; 1-adrenergic stimulation to apoptotic heart cell death through protein kinase A&#x02013;independent activation of Ca 2+/calmodulin kinase II. J Clin Investig. 2003;111(5):617&#x02013;25.<pub-id pub-id-type="pmid">12618516</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>L-H</given-names></name><etal/></person-group><article-title>Oxidative stress&#x02013;induced afterdepolarizations and calmodulin kinase II signaling</article-title><source>Circ Res</source><year>2009</year><volume>104</volume><issue>1</issue><fpage>79</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.183475</pub-id><pub-id pub-id-type="pmid">19038865</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Xie L-H, et al. Oxidative stress&#x02013;induced afterdepolarizations and calmodulin kinase II signaling. Circ Res. 2009;104(1):79&#x02013;86.<pub-id pub-id-type="pmid">19038865</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>H</given-names></name><etal/></person-group><article-title>Requirement for Ca 2+/calmodulin&#x02013;dependent kinase II in the transition from pressure overload&#x02013;induced cardiac hypertrophy to heart failure in mice</article-title><source>J Clin Investig</source><year>2009</year><volume>119</volume><issue>5</issue><fpage>1230</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.1172/JCI38022</pub-id><pub-id pub-id-type="pmid">19381018</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Ling H, et al. Requirement for Ca 2+/calmodulin&#x02013;dependent kinase II in the transition from pressure overload&#x02013;induced cardiac hypertrophy to heart failure in mice. J Clin Investig. 2009;119(5):1230&#x02013;40.<pub-id pub-id-type="pmid">19381018</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Backs</surname><given-names>J</given-names></name><etal/></person-group><article-title>Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4</article-title><source>Mol Cell Biol</source><year>2008</year><volume>28</volume><issue>10</issue><fpage>3437</fpage><lpage>3445</lpage><pub-id pub-id-type="doi">10.1128/MCB.01611-07</pub-id><pub-id pub-id-type="pmid">18332106</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Backs J, et al. Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4. Mol Cell Biol. 2008;28(10):3437&#x02013;45.<pub-id pub-id-type="pmid">18332106</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Neubauer</surname><given-names>S</given-names></name></person-group><article-title>The failing heart - an engine out of fuel</article-title><source>N Engl J Med</source><year>2007</year><volume>356</volume><issue>11</issue><fpage>1140</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1056/NEJMra063052</pub-id><pub-id pub-id-type="pmid">17360992</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Neubauer S. The failing heart - an engine out of fuel. N Engl J Med. 2007;356(11):1140&#x02013;51.<pub-id pub-id-type="pmid">17360992</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Neubauer</surname><given-names>S</given-names></name><etal/></person-group><article-title>Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy</article-title><source>Circulation</source><year>1997</year><volume>96</volume><issue>7</issue><fpage>2190</fpage><lpage>2196</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.96.7.2190</pub-id><pub-id pub-id-type="pmid">9337189</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Neubauer S, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation. 1997;96(7):2190&#x02013;6.<pub-id pub-id-type="pmid">9337189</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Bottomley</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death</article-title><source>Sci Transl Med</source><year>2013</year><volume>5</volume><issue>215</issue><fpage>215re3</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.3007328</pub-id><pub-id pub-id-type="pmid">24337482</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Bottomley PA, et al. Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death. Sci Transl Med. 2013;5(215):215re3.<pub-id pub-id-type="pmid">24337482</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A</given-names></name><etal/></person-group><article-title>Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved</article-title><source>J Clin Invest</source><year>2012</year><volume>122</volume><issue>1</issue><fpage>291</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1172/JCI57426</pub-id><pub-id pub-id-type="pmid">22201686</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Gupta A, et al. Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J Clin Invest. 2012;122(1):291&#x02013;302.<pub-id pub-id-type="pmid">22201686</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Lygate</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice</article-title><source>Circ Res</source><year>2013</year><volume>112</volume><issue>6</issue><fpage>945</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.300725</pub-id><pub-id pub-id-type="pmid">23325497</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Lygate CA, et al. Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice. Circ Res. 2013;112(6):945&#x02013;55.<pub-id pub-id-type="pmid">23325497</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>WD</given-names></name><etal/></person-group><article-title>Retained metabolic flexibility of the failing human heart</article-title><source>Circulation</source><year>2023</year><volume>148</volume><issue>2</issue><fpage>109</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.122.062166</pub-id><pub-id pub-id-type="pmid">37199155</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Watson WD, et al. Retained metabolic flexibility of the failing human heart. Circulation. 2023;148(2):109&#x02013;23.<pub-id pub-id-type="pmid">37199155</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Chaanine</surname><given-names>AH</given-names></name><etal/></person-group><article-title>Mitochondrial morphology, dynamics, and function in human pressure overload or ischemic heart disease with preserved or reduced ejection fraction</article-title><source>Circ Heart Fail</source><year>2019</year><volume>12</volume><issue>2</issue><fpage>e005131</fpage><pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.118.005131</pub-id><pub-id pub-id-type="pmid">30744415</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Chaanine AH, et al. Mitochondrial morphology, dynamics, and function in human pressure overload or ischemic heart disease with preserved or reduced ejection fraction. Circ Heart Fail. 2019;12(2):e005131.<pub-id pub-id-type="pmid">30744415</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Sabbah</surname><given-names>HN</given-names></name><etal/></person-group><article-title>Mitochondrial abnormalities in myocardium of dogs with chronic heart failure</article-title><source>J Mol Cell Cardiol</source><year>1992</year><volume>24</volume><issue>11</issue><fpage>1333</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1016/0022-2828(92)93098-5</pub-id><pub-id pub-id-type="pmid">1479624</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Sabbah HN, et al. Mitochondrial abnormalities in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol. 1992;24(11):1333&#x02013;47.<pub-id pub-id-type="pmid">1479624</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Gladden</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Novel insights into interactions between mitochondria and xanthine oxidase in acute cardiac volume overload</article-title><source>Free Radical Biol Med</source><year>2011</year><volume>51</volume><issue>11</issue><fpage>1975</fpage><lpage>1984</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.08.022</pub-id><pub-id pub-id-type="pmid">21925594</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Gladden JD, et al. Novel insights into interactions between mitochondria and xanthine oxidase in acute cardiac volume overload. Free Radical Biol Med. 2011;51(11):1975&#x02013;84.<pub-id pub-id-type="pmid">21925594</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><etal/></person-group><article-title>CaMKII induces permeability transition through Drp1 phosphorylation during chronic &#x003b2;-AR stimulation</article-title><source>Nat Commun</source><year>2016</year><volume>7</volume><issue>1</issue><fpage>13189</fpage><pub-id pub-id-type="doi">10.1038/ncomms13189</pub-id><pub-id pub-id-type="pmid">27739424</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Xu S, et al. CaMKII induces permeability transition through Drp1 phosphorylation during chronic &#x003b2;-AR stimulation. Nat Commun. 2016;7(1):13189.<pub-id pub-id-type="pmid">27739424</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><etal/></person-group><article-title>Mitochondrial OPA1, apoptosis, and heart failure</article-title><source>Cardiovasc Res</source><year>2009</year><volume>84</volume><issue>1</issue><fpage>91</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvp181</pub-id><pub-id pub-id-type="pmid">19493956</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Chen L, et al. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc Res. 2009;84(1):91&#x02013;9.<pub-id pub-id-type="pmid">19493956</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshino</surname><given-names>A</given-names></name><etal/></person-group><article-title>Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart</article-title><source>Nat Commun</source><year>2013</year><volume>4</volume><issue>1</issue><fpage>2308</fpage><pub-id pub-id-type="doi">10.1038/ncomms3308</pub-id><pub-id pub-id-type="pmid">23917356</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Hoshino A, et al. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat Commun. 2013;4(1):2308.<pub-id pub-id-type="pmid">23917356</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Billia</surname><given-names>F</given-names></name><etal/></person-group><article-title>PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function</article-title><source>Proc Natl Acad Sci</source><year>2011</year><volume>108</volume><issue>23</issue><fpage>9572</fpage><lpage>9577</lpage><pub-id pub-id-type="doi">10.1073/pnas.1106291108</pub-id><pub-id pub-id-type="pmid">21606348</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Billia F, et al. PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. Proc Natl Acad Sci. 2011;108(23):9572&#x02013;7.<pub-id pub-id-type="pmid">21606348</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Kiyuna</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities</article-title><source>Free Radical Biol Med</source><year>2018</year><volume>129</volume><fpage>155</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.09.019</pub-id><pub-id pub-id-type="pmid">30227272</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Kiyuna LA, et al. Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities. Free Radical Biol Med. 2018;129:155&#x02013;68.<pub-id pub-id-type="pmid">30227272</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Bertero</surname><given-names>E</given-names></name><name><surname>Maack</surname><given-names>C</given-names></name></person-group><article-title>Calcium signaling and reactive oxygen species in mitochondria</article-title><source>Circ Res</source><year>2018</year><volume>122</volume><issue>10</issue><fpage>1460</fpage><lpage>1478</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.118.310082</pub-id><pub-id pub-id-type="pmid">29748369</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Bertero E, Maack C. Calcium signaling and reactive oxygen species in mitochondria. Circ Res. 2018;122(10):1460&#x02013;78.<pub-id pub-id-type="pmid">29748369</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Chouchani</surname><given-names>ET</given-names></name><etal/></person-group><article-title>Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS</article-title><source>Nature</source><year>2014</year><volume>515</volume><issue>7527</issue><fpage>431</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1038/nature13909</pub-id><pub-id pub-id-type="pmid">25383517</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Chouchani ET, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515(7527):431&#x02013;5.<pub-id pub-id-type="pmid">25383517</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Aikawa</surname><given-names>R</given-names></name><etal/></person-group><article-title>Reactive oxygen species in mechanical stress-induced cardiac hypertrophy</article-title><source>Biochem Biophys Res Commun</source><year>2001</year><volume>289</volume><issue>4</issue><fpage>901</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.6068</pub-id><pub-id pub-id-type="pmid">11735132</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Aikawa R, et al. Reactive oxygen species in mechanical stress-induced cardiac hypertrophy. Biochem Biophys Res Commun. 2001;289(4):901&#x02013;7.<pub-id pub-id-type="pmid">11735132</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Prosser</surname><given-names>BL</given-names></name><name><surname>Ward</surname><given-names>CW</given-names></name><name><surname>Lederer</surname><given-names>W</given-names></name></person-group><article-title>X-ROS signaling: rapid mechano-chemo transduction in heart</article-title><source>Science</source><year>2011</year><volume>333</volume><issue>6048</issue><fpage>1440</fpage><lpage>1445</lpage><pub-id pub-id-type="doi">10.1126/science.1202768</pub-id><pub-id pub-id-type="pmid">21903813</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Prosser BL, Ward CW, Lederer W. X-ROS signaling: rapid mechano-chemo transduction in heart. Science. 2011;333(6048):1440&#x02013;5.<pub-id pub-id-type="pmid">21903813</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Khairallah</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Microtubules underlie dysfunction in duchenne muscular dystrophy</article-title><source>Sci Signaling</source><year>2012</year><volume>5</volume><issue>236</issue><fpage>ra56</fpage><pub-id pub-id-type="doi">10.1126/scisignal.2002829</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Khairallah RJ, et al. Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci Signaling. 2012;5(236):ra56.</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Lokuta</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure</article-title><source>Circulation</source><year>2005</year><volume>111</volume><issue>8</issue><fpage>988</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000156461.81529.D7</pub-id><pub-id pub-id-type="pmid">15710754</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Lokuta AJ, et al. Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure. Circulation. 2005;111(8):988&#x02013;95.<pub-id pub-id-type="pmid">15710754</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Sabri</surname><given-names>A</given-names></name><name><surname>Hughie</surname><given-names>HH</given-names></name><name><surname>Lucchesi</surname><given-names>PA</given-names></name></person-group><article-title>Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes</article-title><source>Antioxid Redox Signal</source><year>2003</year><volume>5</volume><issue>6</issue><fpage>731</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1089/152308603770380034</pub-id><pub-id pub-id-type="pmid">14588146</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Sabri A, Hughie HH, Lucchesi PA. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal. 2003;5(6):731&#x02013;40.<pub-id pub-id-type="pmid">14588146</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Giulivi</surname><given-names>C</given-names></name><name><surname>Boveris</surname><given-names>A</given-names></name><name><surname>Cadenas</surname><given-names>E</given-names></name></person-group><article-title>Hydroxyl radical generation during mitochondrial electron-transfer and the formation of 8-hydroxydesoxyguanosine in mitochondrial-DNA</article-title><source>Arch Biochem Biophys</source><year>1995</year><volume>316</volume><issue>2</issue><fpage>909</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1006/abbi.1995.1122</pub-id><pub-id pub-id-type="pmid">7864650</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Giulivi C, Boveris A, Cadenas E. Hydroxyl radical generation during mitochondrial electron-transfer and the formation of 8-hydroxydesoxyguanosine in mitochondrial-DNA. Arch Biochem Biophys. 1995;316(2):909&#x02013;16.<pub-id pub-id-type="pmid">7864650</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Spinale</surname><given-names>FG</given-names></name><etal/></person-group><article-title>Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function</article-title><source>Circ Res</source><year>1998</year><volume>82</volume><issue>4</issue><fpage>482</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1161/01.RES.82.4.482</pub-id><pub-id pub-id-type="pmid">9506709</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Spinale FG, et al. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res. 1998;82(4):482&#x02013;95.<pub-id pub-id-type="pmid">9506709</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Cesselli</surname><given-names>D</given-names></name><etal/></person-group><article-title>Oxidative stress&#x02013;mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy</article-title><source>Circ Res</source><year>2001</year><volume>89</volume><issue>3</issue><fpage>279</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1161/hh1501.094115</pub-id><pub-id pub-id-type="pmid">11485979</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Cesselli D, et al. Oxidative stress&#x02013;mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res. 2001;89(3):279&#x02013;86.<pub-id pub-id-type="pmid">11485979</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation</article-title><source>Science</source><year>1998</year><volume>279</volume><issue>5348</issue><fpage>234</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1126/science.279.5348.234</pub-id><pub-id pub-id-type="pmid">9422697</pub-id>
</element-citation><mixed-citation id="mc-CR82" publication-type="journal">Xu L, et al. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science. 1998;279(5348):234&#x02013;7.<pub-id pub-id-type="pmid">9422697</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Nishino</surname><given-names>T</given-names></name><name><surname>Nishino</surname><given-names>T</given-names></name></person-group><article-title>The conversion from the dehydrogenase type to the oxidase type of rat liver xanthine dehydrogenase by modification of cysteine residues with fluorodinitrobenzene</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><issue>47</issue><fpage>29859</fpage><lpage>29864</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.47.29859</pub-id><pub-id pub-id-type="pmid">9368059</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Nishino T, Nishino T. The conversion from the dehydrogenase type to the oxidase type of rat liver xanthine dehydrogenase by modification of cysteine residues with fluorodinitrobenzene. J Biol Chem. 1997;272(47):29859&#x02013;64.<pub-id pub-id-type="pmid">9368059</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Haworth</surname><given-names>RA</given-names></name><name><surname>Hunter</surname><given-names>DR</given-names></name></person-group><article-title>The Ca2+-induced membrane transition in mitochondria: II. Nature of the Ca2+ trigger site</article-title><source>Arch Biochem Biophysics</source><year>1979</year><volume>195</volume><issue>2</issue><fpage>460</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(79)90372-2</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Haworth RA, Hunter DR. The Ca2+-induced membrane transition in mitochondria: II. Nature of the Ca2+ trigger site. Arch Biochem Biophysics. 1979;195(2):460&#x02013;7.</mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Chappell</surname><given-names>J</given-names></name><name><surname>Crofts</surname><given-names>A</given-names></name></person-group><article-title>Calcium ion accumulation and volume changes of isolated liver mitochondria Calcium ion-induced swelling</article-title><source>Biochem J</source><year>1965</year><volume>95</volume><issue>2</issue><fpage>378</fpage><pub-id pub-id-type="doi">10.1042/bj0950378</pub-id><pub-id pub-id-type="pmid">14340088</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Chappell J, Crofts A. Calcium ion accumulation and volume changes of isolated liver mitochondria Calcium ion-induced swelling. Biochem J. 1965;95(2):378.<pub-id pub-id-type="pmid">14340088</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name><surname>Halestrap</surname><given-names>AP</given-names></name></person-group><article-title>What is the mitochondrial permeability transition pore?</article-title><source>J Mol Cell Cardiol</source><year>2009</year><volume>46</volume><issue>6</issue><fpage>821</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.02.021</pub-id><pub-id pub-id-type="pmid">19265700</pub-id>
</element-citation><mixed-citation id="mc-CR86" publication-type="journal">Halestrap AP. What is the mitochondrial permeability transition pore? J Mol Cell Cardiol. 2009;46(6):821&#x02013;31.<pub-id pub-id-type="pmid">19265700</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name><surname>Kwong</surname><given-names>JQ</given-names></name><name><surname>Molkentin</surname><given-names>JD</given-names></name></person-group><article-title>Physiological and pathological roles of the mitochondrial permeability transition pore in the heart</article-title><source>Cell Metab</source><year>2015</year><volume>21</volume><issue>2</issue><fpage>206</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.12.001</pub-id><pub-id pub-id-type="pmid">25651175</pub-id>
</element-citation><mixed-citation id="mc-CR87" publication-type="journal">Kwong JQ, Molkentin JD. Physiological and pathological roles of the mitochondrial permeability transition pore in the heart. Cell Metab. 2015;21(2):206&#x02013;14.<pub-id pub-id-type="pmid">25651175</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Superoxide flashes in single mitochondria</article-title><source>Cell</source><year>2008</year><volume>134</volume><issue>2</issue><fpage>279</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.06.017</pub-id><pub-id pub-id-type="pmid">18662543</pub-id>
</element-citation><mixed-citation id="mc-CR88" publication-type="journal">Wang W, et al. Superoxide flashes in single mitochondria. Cell. 2008;134(2):279&#x02013;90.<pub-id pub-id-type="pmid">18662543</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name><surname>Hom</surname><given-names>JR</given-names></name><etal/></person-group><article-title>The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation</article-title><source>Dev Cell</source><year>2011</year><volume>21</volume><issue>3</issue><fpage>469</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.08.008</pub-id><pub-id pub-id-type="pmid">21920313</pub-id>
</element-citation><mixed-citation id="mc-CR89" publication-type="journal">Hom JR, et al. The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation. Dev Cell. 2011;21(3):469&#x02013;78.<pub-id pub-id-type="pmid">21920313</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardi</surname><given-names>P</given-names></name><name><surname>von Stockum</surname><given-names>S</given-names></name></person-group><article-title>The permeability transition pore as a Ca2+ release channel: new answers to an old question</article-title><source>Cell Calcium</source><year>2012</year><volume>52</volume><issue>1</issue><fpage>22</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2012.03.004</pub-id><pub-id pub-id-type="pmid">22513364</pub-id>
</element-citation><mixed-citation id="mc-CR90" publication-type="journal">Bernardi P, von Stockum S. The permeability transition pore as a Ca2+ release channel: new answers to an old question. Cell Calcium. 2012;52(1):22&#x02013;7.<pub-id pub-id-type="pmid">22513364</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>E</given-names></name><name><surname>Steenbergen</surname><given-names>C</given-names></name></person-group><article-title>Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury</article-title><source>Physiol Rev</source><year>2008</year><volume>88</volume><issue>2</issue><fpage>581</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1152/physrev.00024.2007</pub-id><pub-id pub-id-type="pmid">18391174</pub-id>
</element-citation><mixed-citation id="mc-CR91" publication-type="journal">Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008;88(2):581&#x02013;609.<pub-id pub-id-type="pmid">18391174</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><mixed-citation publication-type="other">Morciano G, Bonora M, Campo G, Aquila G, Rizzo P, Giorgi C, et al. Mechanistic role of&#x000a0;mPTP in ischemia-reperfusion injury.&#x000a0;Mitochond Dyn Cardiovasc Med. 2017;169&#x02013;89.</mixed-citation></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>SY</given-names></name><etal/></person-group><article-title>Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore</article-title><source>Cardiovasc Res</source><year>2007</year><volume>75</volume><issue>3</issue><fpage>530</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2007.04.022</pub-id><pub-id pub-id-type="pmid">17512507</pub-id>
</element-citation><mixed-citation id="mc-CR93" publication-type="journal">Lim SY, et al. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res. 2007;75(3):530&#x02013;5.<pub-id pub-id-type="pmid">17512507</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>H</given-names></name><etal/></person-group><article-title>Ca 2+-and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure</article-title><source>J Clin Investig</source><year>2007</year><volume>117</volume><issue>9</issue><fpage>2431</fpage><lpage>2444</lpage><pub-id pub-id-type="doi">10.1172/JCI31060</pub-id><pub-id pub-id-type="pmid">17694179</pub-id>
</element-citation><mixed-citation id="mc-CR94" publication-type="journal">Nakayama H, et al. Ca 2+-and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Investig. 2007;117(9):2431&#x02013;44.<pub-id pub-id-type="pmid">17694179</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name><surname>Elrod</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Cyclophilin D controls mitochondrial pore&#x02013;dependent Ca 2+ exchange, metabolic flexibility, and propensity for heart failure in mice</article-title><source>J Clin Investig</source><year>2010</year><volume>120</volume><issue>10</issue><fpage>3680</fpage><lpage>3687</lpage><pub-id pub-id-type="doi">10.1172/JCI43171</pub-id><pub-id pub-id-type="pmid">20890047</pub-id>
</element-citation><mixed-citation id="mc-CR95" publication-type="journal">Elrod JW, et al. Cyclophilin D controls mitochondrial pore&#x02013;dependent Ca 2+ exchange, metabolic flexibility, and propensity for heart failure in mice. J Clin Investig. 2010;120(10):3680&#x02013;7.<pub-id pub-id-type="pmid">20890047</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>P-H</given-names></name><name><surname>Chen</surname><given-names>H-Z</given-names></name></person-group><article-title>Cardiomyocyte senescence and cellular communications within myocardial microenvironments</article-title><source>Front Endocrinol</source><year>2020</year><volume>11</volume><fpage>534903</fpage><pub-id pub-id-type="doi">10.3389/fendo.2020.00280</pub-id></element-citation><mixed-citation id="mc-CR96" publication-type="journal">Tang X, Li P-H, Chen H-Z. Cardiomyocyte senescence and cellular communications within myocardial microenvironments. Front Endocrinol. 2020;11: 534903.</mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name><surname>Luan</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Cardiac cell senescence: molecular mechanisms, key proteins and therapeutic targets</article-title><source>Cell Death Discovery</source><year>2024</year><volume>10</volume><issue>1</issue><fpage>78</fpage><pub-id pub-id-type="doi">10.1038/s41420-023-01792-5</pub-id><pub-id pub-id-type="pmid">38355681</pub-id>
</element-citation><mixed-citation id="mc-CR97" publication-type="journal">Luan Y, et al. Cardiac cell senescence: molecular mechanisms, key proteins and therapeutic targets. Cell Death Discovery. 2024;10(1):78.<pub-id pub-id-type="pmid">38355681</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>A</given-names></name><etal/></person-group><article-title>Hypoxia-induced interaction of filamin with Drp1 causes mitochondrial hyperfission&#x02013;associated myocardial senescence</article-title><source>Science Signaling</source><year>2018</year><volume>11</volume><issue>556</issue><fpage>eaat5185</fpage><pub-id pub-id-type="doi">10.1126/scisignal.aat5185</pub-id><pub-id pub-id-type="pmid">30425165</pub-id>
</element-citation><mixed-citation id="mc-CR98" publication-type="journal">Nishimura A, et al. Hypoxia-induced interaction of filamin with Drp1 causes mitochondrial hyperfission&#x02013;associated myocardial senescence. Science Signaling. 2018;11(556):eaat5185.<pub-id pub-id-type="pmid">30425165</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>R</given-names></name><etal/></person-group><article-title>Length-independent telomere damage drives post-mitotic cardiomyocyte senescence</article-title><source>EMBO J</source><year>2019</year><volume>38</volume><issue>5</issue><fpage>e100492</fpage><pub-id pub-id-type="doi">10.15252/embj.2018100492</pub-id><pub-id pub-id-type="pmid">30737259</pub-id>
</element-citation><mixed-citation id="mc-CR99" publication-type="journal">Anderson R, et al. Length-independent telomere damage drives post-mitotic cardiomyocyte senescence. EMBO J. 2019;38(5): e100492.<pub-id pub-id-type="pmid">30737259</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D</given-names></name><etal/></person-group><article-title>DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><issue>1</issue><fpage>1307</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-09014-2</pub-id><pub-id pub-id-type="pmid">30898999</pub-id>
</element-citation><mixed-citation id="mc-CR100" publication-type="journal">Zhang D, et al. DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation. Nat Commun. 2019;10(1):1307.<pub-id pub-id-type="pmid">30898999</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name><surname>Longnus</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Mitochondrial damage-associated molecular patterns as potential biomarkers in DCD heart transplantation: lessons from myocardial infarction and cardiac arrest</article-title><source>Transplantation direct</source><year>2022</year><volume>8</volume><issue>1</issue><fpage>e1265</fpage><pub-id pub-id-type="doi">10.1097/TXD.0000000000001265</pub-id><pub-id pub-id-type="pmid">34934807</pub-id>
</element-citation><mixed-citation id="mc-CR101" publication-type="journal">Longnus SL, et al. Mitochondrial damage-associated molecular patterns as potential biomarkers in DCD heart transplantation: lessons from myocardial infarction and cardiac arrest. Transplantation direct. 2022;8(1):e1265.<pub-id pub-id-type="pmid">34934807</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B</given-names></name><etal/></person-group><article-title>Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure</article-title><source>J Clin Investig</source><year>2020</year><volume>130</volume><issue>11</issue><fpage>6054</fpage><lpage>6063</lpage><pub-id pub-id-type="doi">10.1172/JCI138538</pub-id><pub-id pub-id-type="pmid">32790648</pub-id>
</element-citation><mixed-citation id="mc-CR102" publication-type="journal">Zhou B, et al. Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure. J Clin Investig. 2020;130(11):6054&#x02013;63.<pub-id pub-id-type="pmid">32790648</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>JS</given-names></name><name><surname>Tait</surname><given-names>SW</given-names></name></person-group><article-title>Mitochondrial DNA in inflammation and immunity</article-title><source>EMBO Rep</source><year>2020</year><volume>21</volume><issue>4</issue><fpage>e49799</fpage><pub-id pub-id-type="doi">10.15252/embr.201949799</pub-id><pub-id pub-id-type="pmid">32202065</pub-id>
</element-citation><mixed-citation id="mc-CR103" publication-type="journal">Riley JS, Tait SW. Mitochondrial DNA in inflammation and immunity. EMBO Rep. 2020;21(4): e49799.<pub-id pub-id-type="pmid">32202065</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress</article-title><source>Biomed Pharmacother</source><year>2020</year><volume>125</volume><fpage>110022</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2020.110022</pub-id><pub-id pub-id-type="pmid">32106379</pub-id>
</element-citation><mixed-citation id="mc-CR104" publication-type="journal">Zhang Y, Chen W, Wang Y. STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress. Biomed Pharmacother. 2020;125: 110022.<pub-id pub-id-type="pmid">32106379</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><etal/></person-group><article-title>Nanoplastics causes heart aging/myocardial cell senescence through the Ca2+/mtDNA/cGAS-STING signaling cascade</article-title><source>J Nanobiotechnol</source><year>2024</year><volume>22</volume><issue>1</issue><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1186/s12951-023-02253-y</pub-id></element-citation><mixed-citation id="mc-CR105" publication-type="journal">Wang K, et al. Nanoplastics causes heart aging/myocardial cell senescence through the Ca2+/mtDNA/cGAS-STING signaling cascade. J Nanobiotechnol. 2024;22(1):1&#x02013;23.</mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name><surname>Oduro</surname><given-names>PK</given-names></name><etal/></person-group><article-title>The cGAS&#x02013;STING signaling in cardiovascular and metabolic diseases: future novel target option for pharmacotherapy</article-title><source>Acta Pharmaceutica Sinica B</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>50</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.apsb.2021.05.011</pub-id><pub-id pub-id-type="pmid">35127372</pub-id>
</element-citation><mixed-citation id="mc-CR106" publication-type="journal">Oduro PK, et al. The cGAS&#x02013;STING signaling in cardiovascular and metabolic diseases: future novel target option for pharmacotherapy. Acta Pharmaceutica Sinica B. 2022;12(1):50&#x02013;75.<pub-id pub-id-type="pmid">35127372</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name><surname>Oka</surname><given-names>T</given-names></name><etal/></person-group><article-title>Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure</article-title><source>Nature</source><year>2012</year><volume>485</volume><issue>7397</issue><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1038/nature10992</pub-id><pub-id pub-id-type="pmid">22535248</pub-id>
</element-citation><mixed-citation id="mc-CR107" publication-type="journal">Oka T, et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature. 2012;485(7397):251&#x02013;5.<pub-id pub-id-type="pmid">22535248</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>